About ADARx Pharmaceuticals
ADARx Pharmaceuticals is a company based in San Diego (United States) founded in 2019 by Zhen Li.. ADARx Pharmaceuticals has raised $352.5 million across 7 funding rounds from investors including BlackRock, T. Rowe Price and Marshall Wace. The company has 44 employees as of December 31, 2022. ADARx Pharmaceuticals offers products and services including RNA Medicines. ADARx Pharmaceuticals operates in a competitive market with competitors including Poseida Therapeutics, Senti Biosciences, CRISPR Therapeutics, WhiteLab Genomics and OXGENE, among others.
- Headquarter San Diego, United States
- Employees 44 as on 31 Dec, 2022
- Founders Zhen Li
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adarx Pharmaceuticals Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$352.5 M (USD)
in 7 rounds
-
Latest Funding Round
$200 M (USD), Series C
Aug 02, 2023
-
Investors
BlackRock
& 17 more
-
Employee Count
44
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADARx Pharmaceuticals
ADARx Pharmaceuticals offers a comprehensive portfolio of products and services, including RNA Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments that silence disease-causing genes via RNA technology
Unlock access to complete
Unlock access to complete
Funding Insights of ADARx Pharmaceuticals
ADARx Pharmaceuticals has successfully raised a total of $352.5M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $200 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $200.0M
-
First Round
First Round
(24 Jan 2020)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series C - ADARx Pharmaceuticals | Valuation | Bain Capital Life Sciences , TCG Crossover | |
| Jan, 2023 | Amount | Series C - ADARx Pharmaceuticals | Valuation | Ascenta Capital | |
| Jul, 2021 | Amount | Series C - ADARx Pharmaceuticals | Valuation | SR One , Orbimed |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ADARx Pharmaceuticals
ADARx Pharmaceuticals has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include BlackRock, T. Rowe Price and Marshall Wace. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is provided to healthcare startups by Commodore Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ADARx Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ADARx Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adarx Pharmaceuticals Comparisons
Competitors of ADARx Pharmaceuticals
ADARx Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Poseida Therapeutics, Senti Biosciences, CRISPR Therapeutics, WhiteLab Genomics and OXGENE, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing.
|
|
| domain | founded_year | HQ Location |
AI platform for drug discovery and development is provided.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for mammalian cell engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adarx Pharmaceuticals
Frequently Asked Questions about ADARx Pharmaceuticals
When was ADARx Pharmaceuticals founded?
ADARx Pharmaceuticals was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is ADARx Pharmaceuticals located?
ADARx Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of ADARx Pharmaceuticals?
Zhen Li is the current CEO of ADARx Pharmaceuticals. They have also founded this company.
Is ADARx Pharmaceuticals a funded company?
ADARx Pharmaceuticals is a funded company, having raised a total of $352.5M across 7 funding rounds to date. The company's 1st funding round was a Series C of $75M, raised on Jan 24, 2020.
How many employees does ADARx Pharmaceuticals have?
As of Dec 31, 2022, the latest employee count at ADARx Pharmaceuticals is 44.
What does ADARx Pharmaceuticals do?
ADARx Pharmaceuticals was founded in 2019 in San Diego, United States. Genetic therapeutic solutions are developed to target and edit single point mutations on RNA transcripts. Precise modifications are made to nucleotide sequences in transcripts, enabling production of desired proteins from genomic templates. Operations focus on biotechnology applications for therapeutic editing, with leadership provided by co-founder and CEO Zhen Li.
Who are the top competitors of ADARx Pharmaceuticals?
ADARx Pharmaceuticals's top competitors include CRISPR Therapeutics, Senti Biosciences and Poseida Therapeutics.
What products or services does ADARx Pharmaceuticals offer?
ADARx Pharmaceuticals offers RNA Medicines.
Who are ADARx Pharmaceuticals's investors?
ADARx Pharmaceuticals has 18 investors. Key investors include BlackRock, T. Rowe Price, Marshall Wace, Orbimed, and HBM Healthcare Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.